You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

15 Items

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Document Status: In-Review
ID: 3-22
Version: N/A

Apr 2020

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Document Status: Current

Apr 2020

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Document Status: Current
ID: ES 23-2
Version: N/A

Jun 2020

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Document Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Enhancing Clinical Cancer Genetic Service Delivery in Ontario - Recommendations for a New Model of Care

Document Status: Current
Version: 1.0

Dec 2020

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2020

Document Status: Current
ID: PET 2020-1
Version: N/A

Nov 2020

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2019

Document Status: Current
ID: PET 2019-2
Version: N/A

Jun 2020

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Document Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current
ID: GL 8-10
Version: N/A

Feb 2020

Minimal Residual Disease Testing in Acute Leukemia

Document Status: Current
ID: MOTAC-6
Version: 2

Sep 2020

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Document Status: In-Review
ID: GL END 7-3
Version: 4

Apr 2020

Regional Therapies for Colorectal Cancer Liver Metastases

Document Status: Current
ID: GL 2-30a
Version: N/A

Mar 2020